Antibodies against connective tissue growth factor (CTGF) and their uses
CO20260012198A2Pending Publication Date: 2026-08-31BOEHRINGER INGELHEIM INT GMBH
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CO20260012198
- Authority / Receiving Office
- CO · CO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-02-27
- Filing Date
- 2026-08-24
- Publication Date
- 2026-08-31
Abstract
This disclosure generally refers to anti-CTGF (connective tissue growth factor) antibodies or antigen-binding fragments thereof. The example anti-CTGF antibodies disclosed herein address the need for treatments of conditions modulated by CTGF signaling. In some respects, anti-CTGF antibodies or antigen-binding fragments thereof are for therapeutic and / or diagnostic use, for example, in a subject who needs them, such as a human being.
Need to check novelty before this filing date? Find Prior Art